scispace - formally typeset
S

Shu-Chuen Li

Researcher at University of Newcastle

Publications -  184
Citations -  6155

Shu-Chuen Li is an academic researcher from University of Newcastle. The author has contributed to research in topics: Health care & Population. The author has an hindex of 38, co-authored 181 publications receiving 5465 citations. Previous affiliations of Shu-Chuen Li include Health Sciences Authority & Alfred Hospital.

Papers
More filters
Journal ArticleDOI

A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective.

TL;DR: OPAT is a viable alternative to inpatient care as it is safe, effective and results in lower daily costs, and the trend to longer treatment courses is worthy of further review.
Journal ArticleDOI

Comparison of the EuroQol and short form 6D in Singapore multiethnic asian knee osteoarthritis patients scheduled for total knee replacement

TL;DR: Using different preference-based health-related quality of life instruments may yield different utility scores, which could have a great impact on QALY estimates, and highlights the importance of selecting appropriate instruments for economic evaluation.
Journal ArticleDOI

Statin is a Reasonable Treatment Option for Patients with Polycystic Ovary Syndrome: a Meta-analysis of Randomized Controlled Trials

TL;DR: A meta-analysis to synthesize the literatures regarding therapeutic effects of statins on PCOS concluded that statins can reduce the concentration of total testosterone, TC, TG and LDL, but it cannot be concluded thatstatins have long-term benefit.
Journal ArticleDOI

Validation of the English version of the KINDL generic children's health-related quality of life instrument for an Asian population--results from a pilot test.

TL;DR: The KINDL questionnaire appeared promising for use in Asian children, however, further validation in a sample more representative of the general population is required.
Journal ArticleDOI

Validation and Comparison of EuroQol and Short Form 6D in Chronic Prostatitis Patients

TL;DR: Both EQ-5D and SF- 6D are demonstrated to be valid and sensitive HRQoL measures in Chinese chronic prostatitis patients, with SF-6D showing better HRQeL dimension coverage, greater sensitivity, lower ceiling effect, and more rational distribution.